NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
$8.25 -1 (-10.8108%)
Analysed NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) News Sources
Novartis Trial Failure Sparks Biopharma Options Frenzy
08-09-2026
yahoo.com
How Novartis' Double-Stacked Failures Reverberated Through Biopharma
08-09-2026
yahoo.com
Aclaris (ACRS) Soars 6.0%: Is Further Upside Left in the Stock?
15-09-2026
yahoo.com
NewAmsterdam Pharma (NAMS) Stock Looks Above Fair Value After Its 139% Run
20-09-2026
yahoo.com
NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
21-09-2026
yahoo.com
NewAmsterdam Pharma (NAMS) Wins EU Approvals. Can Cholesterol Pills Drive Royalties?
23-09-2026
yahoo.com
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
29-09-2026
yahoo.com
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-10-2026
yahoo.com
Group 1 Automotive and 4 More Stocks See Action From Activist Investors
02-10-2026
yahoo.com
Does NewAmsterdam Pharma’s (NAMS) Genotype-Targeted SPINOZA Trial Reframe Obicetrapib’s Long-Term Alzheimer’s Strategy?
13-10-2026
yahoo.com
What is the current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is $8.25.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is $-1.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is -10.8108%.
What is the most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is 48 out of 100.
What is the most recent average sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is .
SEC-8K** Filing Available For NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.